Phil Vanek

Dr. Vanek is General Manager of GE Healthcare’s Cell Bioprocessing business, a $6 billion strategy to revolutionize the world’s health by improving the quality, access, and affordability of care. Phil joined GE from Lonza where he was Head of Innovation for Lonza’s pharmaceutical division. Phil’s career has included a number of senior innovations, business and market development roles at Becton Dickinson, Invitrogen, and Life Technologies, as well as two start-up biotechnology companies in the Washington, DC area.